So its the same center when you have an addiction, when you have an opioid or when you drink alcohol, its the same center that gives you the same message: Get this again. GLP-1 drugs have rapidly turned into blockbusters for the companies that make them, also worrying insurance companies with their not-insubstantial price tags
Omega-3 fatty acids for the Management of Osteoarthritis: a narrative review
A., Partridge, L., Serrano, M., & Kroemer, G
The FDA has approved several GLP-1 receptor agonists for type 2 diabetes management and, in some cases, chronic weight management
Resistance training and adequate protein are often discussed, but targets should be individualized
Their higher absorption rate allows you to feel the benefits much faster